🇺🇸 FDA
Patent

US 12145968

Recombinant HIV-1 envelope proteins and their use

granted A61KA61K2039/55555A61K2039/55561

Quick answer

US patent 12145968 (Recombinant HIV-1 envelope proteins and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55555, A61K2039/55561, A61K2039/55577, A61K39/12